Regulatory News
Monday, November 14, 2016
BRIEF-Erytech withdraws its European Marketing Authorization Application for GRASPA
* Erytech announces withdrawal of its European Marketing
Authorization Application for GRASPA for acute lymphoblastic
leukemia and prepares for resubmission
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment